Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes Mellitus
Public ClinicalTrials.gov record NCT01191320. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study to Evaluate the Efficacy of Androxal® in Improving Glycemic Control in Men With Secondary Hypogonadism or Adult-onset Idiopathic Hypogonadotropic Hypogonadism (AIHH) and Type 2 Diabetes Mellitus With Sub-Optimum Treatment
Study identification
- NCT ID
- NCT01191320
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Repros Therapeutics Inc.
- Industry
- Enrollment
- 102 participants
Conditions and interventions
Conditions
Interventions
- Androxal Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 20 Years to 80 Years
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2010
- Primary completion
- Nov 30, 2011
- Completion
- Nov 30, 2011
- Last update posted
- Jul 23, 2014
2010 – 2011
United States locations
- U.S. sites
- 18
- U.S. states
- 5
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Paradigm Clinical Research | Garden Grove | California | 92844 | — |
| Northern California Research Corp | Sacramento | California | 95821 | — |
| LABioMed | Torrance | California | 90502 | — |
| Lahey Clinic | Peabody | Massachusetts | 01960 | — |
| Affiliated Clinical Research | Las Vegas | Nevada | 89109 | — |
| Affiliated Clinical Research | Las Vegas | Nevada | 89144 | — |
| Dr. Bruce Gilbert | Great Neck | New York | 11021 | — |
| University Urology | New York | New York | 10016 | — |
| Mount Sinai School of Medicine | New York | New York | 10029 | — |
| Dr. Michael Werner | Purchase | New York | 10577 | — |
| Discovery Clinical Trials | Austin | Texas | 78758 | — |
| Research Across America | Carrollton | Texas | 75010 | — |
| TX Urology Associate | Houston | Texas | 77024 | — |
| Centex Research | Houston | Texas | 77062 | — |
| Dr. Rakesh Patel | Houston | Texas | 77095 | — |
| Protenium Clinical Research | Hurst | Texas | 76054 | — |
| R/D Clinical Research | Lake Jackson | Texas | 77566 | — |
| Cetero Research | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01191320, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 23, 2014 · Synced May 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01191320 live on ClinicalTrials.gov.